Biblio
CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice. Int J Pharm. 2023:122815.
Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles. Bioimpacts. 2023;13(2):133-144.
.